Skip to main content
. 2016 May;37(5):544–550. doi: 10.15537/smj.2016.5.15032

Figure 2.

Figure 2

Receiver operating characteristic curve showing the performance of dehydroepiandesterone-sulphate in patients with fibromyalgia.